Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion type Assertion NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_head.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion description "[In this paper, we present evidence that decitabine (DAC), a DNA methylation inhibitor that is currently used for the treatment of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and other malignant neoplasms, is capable of eliciting an anti-tumor cytotoxic T lymphocyte (CTL) response in mouse EL4 tumor model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_provenance.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion evidence source_evidence_literature NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_provenance.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion SIO_000772 23671644 NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_provenance.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion wasDerivedFrom befree-20140225 NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_provenance.
- NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_assertion wasGeneratedBy ECO_0000203 NP921462.RAb6kjNUClKkcfjj4RmpcGla4a4VXpflgcwqRkkykrAew130_provenance.